A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
Open Access
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (11) , 1179-1184
- https://doi.org/10.1023/a:1008400706949
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Breast tumour response to primary chemotherapy predicts local and distant control as well as survivalEuropean Journal Of Cancer, 1995
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Primary medical (neo-adjuvant) chemotherapy for operable breast cancerEuropean Journal Of Cancer, 1993
- A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndromeEuropean Journal Of Cancer, 1993
- Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cmAnnals of Oncology, 1991
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancerCancer, 1990
- Primary medical therapy for operable breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977